Valuation: Celltrion, Inc.

Capitalization 45,72900Cr 3.12TCr 2.68TCr 2.5TCr 2.33TCr 4.33TCr 2,81400Cr 4.64TCr 29TCr 11TCr 1,34600Cr 12TCr 11TCr 4,93600Cr P/E ratio 2025 *
55.2x
P/E ratio 2026 * 38.6x
Enterprise value 4.7TCr 3.2Cr 2.76Cr 2.57Cr 2.39Cr 4.44Cr 289.03Cr 4.77Cr 30Cr 12Cr 138.18Cr 12Cr 12Cr 506.91Cr EV / Sales 2025 *
11.3x
EV / Sales 2026 * 9.25x
Free-Float
70.87%
Yield 2025 *
0.35%
Yield 2026 * 0.36%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.71%
1 week-1.88%
Current month+15.47%
1 month+11.29%
3 months+22.08%
6 months+17.02%
Current year+15.47%
More quotes
1 week 2,05,500
Extreme 205500
2,22,500
1 month 1,78,200
Extreme 178200
2,22,500
Current year 1,88,600
Extreme 188600
2,22,500
1 year 1,44,615.38
Extreme 144615.3846
2,22,500
3 years 1,19,963.37
Extreme 119963.37
2,22,500
5 years 1,19,963.37
Extreme 119963.37
3,30,630.28
10 years 65,004.08
Extreme 65004.0844
3,41,497.26
More quotes
Manager TitleAgeSince
Chief Executive Officer - 20/03/2015
Director of Finance/CFO 51 -
Compliance Officer 44 -
Director TitleAgeSince
Chairman 68 -
Director/Board Member 67 17/07/2008
Director/Board Member 67 17/07/2008
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.71%-1.88%+20.29%+35.05% 3.14TCr
-0.92%+1.08%+2.15%+11.43% 4.94TCr
-0.06%-1.20%+21.17%+8.11% 4.11TCr
-0.11%-0.08%+64.42%+26.12% 3.74TCr
-0.31%+3.59%+208.02%+348.87% 2.38TCr
-7.68%-38.80%+21,998.90%+3,675.96% 1.49TCr
+1.00%+4.18%+84.03%+171.13% 1.74TCr
-0.41%+4.16%+54.35%+11.19% 1.49TCr
+0.59%+0.91%-9.60%-18.82% 1.39TCr
-0.95%+6.25%+63.86%+80.25% 1.32TCr
Average -0.90%+0.03%+2,250.76%+434.93% 2.57TCr
Weighted average by Cap. -0.70%+1.11%+1,317.04%+271.49%
See all sector performances

Financials

2025 *2026 *
Net sales 4,15000Cr 282.68Cr 243.5Cr 226.92Cr 211.11Cr 392.74Cr 26TCr 421.3Cr 2.61TCr 1.03TCr 12TCr 1.06TCr 1.04TCr 45TCr 5,02900Cr 342.58Cr 295.09Cr 275.01Cr 255.84Cr 475.96Cr 31TCr 510.57Cr 3.16TCr 1.24TCr 15TCr 1.28TCr 1.26TCr 54TCr
Net income 87TCr 59Cr 51Cr 48Cr 44Cr 82Cr 5.35TCr 88Cr 545.96Cr 214.83Cr 2.56TCr 221.96Cr 217.42Cr 9.38TCr 1,24800Cr 85Cr 73Cr 68Cr 63Cr 118.08Cr 7.68TCr 126.67Cr 783.89Cr 308.46Cr 3.67TCr 318.69Cr 312.17Cr 13TCr
Net Debt 1,23200Cr 84Cr 72Cr 67Cr 63Cr 116.63Cr 7.58TCr 125.11Cr 774.28Cr 304.67Cr 3.63TCr 314.78Cr 308.34Cr 13TCr 80TCr 54Cr 47Cr 44Cr 41Cr 76Cr 4.92TCr 81Cr 502.42Cr 197.7Cr 2.35TCr 204.26Cr 200.08Cr 8.63TCr
More financial data * Estimated data
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,680
More about the company
Date Price Change Volume
16/26/16 2,09,000.00 -0.71% 6,66,660
15/26/15 2,10,500.00 -0.47% 6,08,017
14/26/14 2,11,500.00 -4.30% 9,70,514
13/26/13 2,21,000.00 +3.27% 9,59,413
12/26/12 2,14,000.00 -1.38% 6,92,701

End-of-day quote Korea S.E., January 16, 2026

More quotes
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
2,09,000.00KRW
Average target price
2,35,751.77KRW
Spread / Average Target
+12.80%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A068270 Stock